Monitoring in clinical trials of complementary and alternative medicine

Background: Clinical trial monitoring is an essential activity for quality assurance (QA) to ensure the protection of human rights and the reliability and transparency of the data collection process. The purpose of this article is to enhance the understanding of monitoring process and major findings...

Full description

Bibliographic Details
Main Authors: So-Young Jung, Jung Won Kang, Tae-Hun Kim
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Integrative Medicine Research
Subjects:
CAM
Online Access:http://www.sciencedirect.com/science/article/pii/S2213422020303024
id doaj-24a10a8dcf614f45849c0b4067a5554a
record_format Article
spelling doaj-24a10a8dcf614f45849c0b4067a5554a2021-07-01T04:33:41ZengElsevierIntegrative Medicine Research2213-42202021-06-01102100666Monitoring in clinical trials of complementary and alternative medicineSo-Young Jung0Jung Won Kang1Tae-Hun Kim2Clinical Research Division, Korea Institute of Oriental Medicine, Daejeon, South KoreaDepartment of Acupuncture & Moxibustion, College of Korean Medicine, Kyung Hee University, Seoul, South KoreaKorean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul, South Korea; Corresponding author at: Korean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul, South Korea.Background: Clinical trial monitoring is an essential activity for quality assurance (QA) to ensure the protection of human rights and the reliability and transparency of the data collection process. The purpose of this article is to enhance the understanding of monitoring process and major findings in clinical trials of complementary and alternative medicine (CAM). Methods: Based on International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use (ICH-GCP), we summarized main concept of monitoring process. Personal experiences on monitoring for CAM studies were also narratively described. Results: In this brief article, the basic concept of QA and quality control (QC), various monitoring activities during the study process, and major findings regarding clinical trials of CAM are suggested in an effort to improve understanding of monitoring in clinical research on CAM. Conclusion: When performing clinical trials for CAM-related interventions, the monitoring recommended in GCP is needed to be recognized as a mandatory element in the course of CAM research.http://www.sciencedirect.com/science/article/pii/S2213422020303024MonitoringComplementary and alternative medicineCAMQuality assuranceQuality controlClinical study
collection DOAJ
language English
format Article
sources DOAJ
author So-Young Jung
Jung Won Kang
Tae-Hun Kim
spellingShingle So-Young Jung
Jung Won Kang
Tae-Hun Kim
Monitoring in clinical trials of complementary and alternative medicine
Integrative Medicine Research
Monitoring
Complementary and alternative medicine
CAM
Quality assurance
Quality control
Clinical study
author_facet So-Young Jung
Jung Won Kang
Tae-Hun Kim
author_sort So-Young Jung
title Monitoring in clinical trials of complementary and alternative medicine
title_short Monitoring in clinical trials of complementary and alternative medicine
title_full Monitoring in clinical trials of complementary and alternative medicine
title_fullStr Monitoring in clinical trials of complementary and alternative medicine
title_full_unstemmed Monitoring in clinical trials of complementary and alternative medicine
title_sort monitoring in clinical trials of complementary and alternative medicine
publisher Elsevier
series Integrative Medicine Research
issn 2213-4220
publishDate 2021-06-01
description Background: Clinical trial monitoring is an essential activity for quality assurance (QA) to ensure the protection of human rights and the reliability and transparency of the data collection process. The purpose of this article is to enhance the understanding of monitoring process and major findings in clinical trials of complementary and alternative medicine (CAM). Methods: Based on International Conference on Harmonization of technical requirements for registration of pharmaceuticals for human use (ICH-GCP), we summarized main concept of monitoring process. Personal experiences on monitoring for CAM studies were also narratively described. Results: In this brief article, the basic concept of QA and quality control (QC), various monitoring activities during the study process, and major findings regarding clinical trials of CAM are suggested in an effort to improve understanding of monitoring in clinical research on CAM. Conclusion: When performing clinical trials for CAM-related interventions, the monitoring recommended in GCP is needed to be recognized as a mandatory element in the course of CAM research.
topic Monitoring
Complementary and alternative medicine
CAM
Quality assurance
Quality control
Clinical study
url http://www.sciencedirect.com/science/article/pii/S2213422020303024
work_keys_str_mv AT soyoungjung monitoringinclinicaltrialsofcomplementaryandalternativemedicine
AT jungwonkang monitoringinclinicaltrialsofcomplementaryandalternativemedicine
AT taehunkim monitoringinclinicaltrialsofcomplementaryandalternativemedicine
_version_ 1721347364739874816